Influence of a 100-km ultra-marathon on hepatitis B carrier runners

Y. H. Chiu, S. K. Hou, C. K. How, L. H. Li, W. F. Kao, C. C. Yang, S. L. Chou, Y. T S Shiau, C. Lam, R. J. Chen

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

This study compares the serological markers between runners who are hepatitis B virus carries (HBVc) and runners who are non-HBVc in a 100-km ultra-marathon race. Blood samples of 8 HBVc and 18 non-HBVc runners were drawn 1 week before, immediately following, and 24 h after the race. Samples were analyzed and compared between the 2 groups for liver function tests, muscle damage markers and oxidative stress cytokines. For HBVc runners, HBV-DNA (hepatitis B virus-deoxyribonucleic acid) levels were also evaluated for virus reactivation. The results demonstrate a statistically significant increase in both immediate and 24-h post-race values for alanine aminotransferase (ALT), aspartate aminotransferase (AST), lactate dehydrogenase (LDH), creatine kinase (CK), high-sensitivity C-reactive protein (hs-CRP), interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α), compared with pre-race values. No statistically significant difference was observed between the 2 groups for the values of AST, LDH, CK, hs-CRP, IL-6 and TNF-α either before or after the race. There was also no statistically significant change in the levels of HBV-DNA in HBVc runners. These findings suggest that HBVc runners do not have higher risks of liver function impairment, muscle breakdown and inflammatory response compared to non-HBVc runners in such endurance races.

Original languageEnglish
Pages (from-to)841-845
Number of pages5
JournalInternational Journal of Sports Medicine
Volume34
Issue number9
DOIs
Publication statusPublished - 2013

Fingerprint

Hepatitis B
Hepatitis B virus
Cercopithecine Herpesvirus 1
Creatine Kinase
Aspartate Aminotransferases
L-Lactate Dehydrogenase
C-Reactive Protein
Interleukin-6
Tumor Necrosis Factor-alpha
Muscles
Liver Function Tests
DNA
Alanine Transaminase
Oxidative Stress
Cytokines
Viruses
Liver

Keywords

  • clinical sports medicine
  • hepatitis B virus carrier runner
  • inflammatory response
  • liver function impairment
  • ultra-marathon

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine
  • Medicine(all)

Cite this

Influence of a 100-km ultra-marathon on hepatitis B carrier runners. / Chiu, Y. H.; Hou, S. K.; How, C. K.; Li, L. H.; Kao, W. F.; Yang, C. C.; Chou, S. L.; Shiau, Y. T S; Lam, C.; Chen, R. J.

In: International Journal of Sports Medicine, Vol. 34, No. 9, 2013, p. 841-845.

Research output: Contribution to journalArticle

Chiu, Y. H. ; Hou, S. K. ; How, C. K. ; Li, L. H. ; Kao, W. F. ; Yang, C. C. ; Chou, S. L. ; Shiau, Y. T S ; Lam, C. ; Chen, R. J. / Influence of a 100-km ultra-marathon on hepatitis B carrier runners. In: International Journal of Sports Medicine. 2013 ; Vol. 34, No. 9. pp. 841-845.
@article{99758e0a15ec4344b2cb0ebfe32f6bfb,
title = "Influence of a 100-km ultra-marathon on hepatitis B carrier runners",
abstract = "This study compares the serological markers between runners who are hepatitis B virus carries (HBVc) and runners who are non-HBVc in a 100-km ultra-marathon race. Blood samples of 8 HBVc and 18 non-HBVc runners were drawn 1 week before, immediately following, and 24 h after the race. Samples were analyzed and compared between the 2 groups for liver function tests, muscle damage markers and oxidative stress cytokines. For HBVc runners, HBV-DNA (hepatitis B virus-deoxyribonucleic acid) levels were also evaluated for virus reactivation. The results demonstrate a statistically significant increase in both immediate and 24-h post-race values for alanine aminotransferase (ALT), aspartate aminotransferase (AST), lactate dehydrogenase (LDH), creatine kinase (CK), high-sensitivity C-reactive protein (hs-CRP), interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α), compared with pre-race values. No statistically significant difference was observed between the 2 groups for the values of AST, LDH, CK, hs-CRP, IL-6 and TNF-α either before or after the race. There was also no statistically significant change in the levels of HBV-DNA in HBVc runners. These findings suggest that HBVc runners do not have higher risks of liver function impairment, muscle breakdown and inflammatory response compared to non-HBVc runners in such endurance races.",
keywords = "clinical sports medicine, hepatitis B virus carrier runner, inflammatory response, liver function impairment, ultra-marathon",
author = "Chiu, {Y. H.} and Hou, {S. K.} and How, {C. K.} and Li, {L. H.} and Kao, {W. F.} and Yang, {C. C.} and Chou, {S. L.} and Shiau, {Y. T S} and C. Lam and Chen, {R. J.}",
year = "2013",
doi = "10.1055/s-0032-1331769",
language = "English",
volume = "34",
pages = "841--845",
journal = "International Journal of Sports Medicine",
issn = "0172-4622",
publisher = "Georg Thieme Verlag",
number = "9",

}

TY - JOUR

T1 - Influence of a 100-km ultra-marathon on hepatitis B carrier runners

AU - Chiu, Y. H.

AU - Hou, S. K.

AU - How, C. K.

AU - Li, L. H.

AU - Kao, W. F.

AU - Yang, C. C.

AU - Chou, S. L.

AU - Shiau, Y. T S

AU - Lam, C.

AU - Chen, R. J.

PY - 2013

Y1 - 2013

N2 - This study compares the serological markers between runners who are hepatitis B virus carries (HBVc) and runners who are non-HBVc in a 100-km ultra-marathon race. Blood samples of 8 HBVc and 18 non-HBVc runners were drawn 1 week before, immediately following, and 24 h after the race. Samples were analyzed and compared between the 2 groups for liver function tests, muscle damage markers and oxidative stress cytokines. For HBVc runners, HBV-DNA (hepatitis B virus-deoxyribonucleic acid) levels were also evaluated for virus reactivation. The results demonstrate a statistically significant increase in both immediate and 24-h post-race values for alanine aminotransferase (ALT), aspartate aminotransferase (AST), lactate dehydrogenase (LDH), creatine kinase (CK), high-sensitivity C-reactive protein (hs-CRP), interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α), compared with pre-race values. No statistically significant difference was observed between the 2 groups for the values of AST, LDH, CK, hs-CRP, IL-6 and TNF-α either before or after the race. There was also no statistically significant change in the levels of HBV-DNA in HBVc runners. These findings suggest that HBVc runners do not have higher risks of liver function impairment, muscle breakdown and inflammatory response compared to non-HBVc runners in such endurance races.

AB - This study compares the serological markers between runners who are hepatitis B virus carries (HBVc) and runners who are non-HBVc in a 100-km ultra-marathon race. Blood samples of 8 HBVc and 18 non-HBVc runners were drawn 1 week before, immediately following, and 24 h after the race. Samples were analyzed and compared between the 2 groups for liver function tests, muscle damage markers and oxidative stress cytokines. For HBVc runners, HBV-DNA (hepatitis B virus-deoxyribonucleic acid) levels were also evaluated for virus reactivation. The results demonstrate a statistically significant increase in both immediate and 24-h post-race values for alanine aminotransferase (ALT), aspartate aminotransferase (AST), lactate dehydrogenase (LDH), creatine kinase (CK), high-sensitivity C-reactive protein (hs-CRP), interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α), compared with pre-race values. No statistically significant difference was observed between the 2 groups for the values of AST, LDH, CK, hs-CRP, IL-6 and TNF-α either before or after the race. There was also no statistically significant change in the levels of HBV-DNA in HBVc runners. These findings suggest that HBVc runners do not have higher risks of liver function impairment, muscle breakdown and inflammatory response compared to non-HBVc runners in such endurance races.

KW - clinical sports medicine

KW - hepatitis B virus carrier runner

KW - inflammatory response

KW - liver function impairment

KW - ultra-marathon

UR - http://www.scopus.com/inward/record.url?scp=84883490249&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84883490249&partnerID=8YFLogxK

U2 - 10.1055/s-0032-1331769

DO - 10.1055/s-0032-1331769

M3 - Article

VL - 34

SP - 841

EP - 845

JO - International Journal of Sports Medicine

JF - International Journal of Sports Medicine

SN - 0172-4622

IS - 9

ER -